Program
Presidential Address
Toshiaki Saeki
(Department of Breast Oncology, Saitama Medical University International Medical Center)
Symposium
- Cancer Genomics and Breast Cancer Treatment
- Advances in Genomic and Epigenomic Analysis
- Role of Multigene Analysis in the Treatment of Breast Cancer
- Rapidly Evolving Genome Medicine
― Do you care for patients diagnosed with hereditary cancer that has been secondarily detected? - Breast Specialists and Genome Medicine “Prospects of Cancer Genome Medicine for Breast Cancer” (partial designation/public offering session planned)
- HER2 negative breast cancer(early, metastatic)
- HER2 positive breast cancer(early, metastatic)
- Mastectomy and Breast Reconstruction – Evolution of and Appropriate Indication for Surgical Procedures (designation/partial public offering session planned)
- Paradigm Shift in the Surgical Treatment of Breast Cancer
- Curing Metastatic Breast Cancer – Paradigm Shift in the Treatment of Breast Cancer
- Management of Adverse Event of Drug Therapy
- Mechanism of changing sensitivity for endcrine therapy
- Sequelae Associated with Treatment (public offering session planned)
- Breast Cancer in Elderly Patients (public offering session planned)
- Advanced Care Planning
- Toward an Accurate Pathological Diagnosis of Mammary Gland Tumors
- Current Status of and Problems with Radiotherapy for Breast Cancer
- Measures for Dense Breasts and Potential New Screening Approaches
- Supportive care for breast cancer patients with a team of multi-disciplinary medical staffs
- Treatment of Metastatic Breast Cancer in Cooperation with Other Departments (partial designation/public offering session planned)
- Augmented Intelligence (Extended Intelligence) (partial designation/public offering session planned)
- Care for Breast cancer survivors in USA, EU and Asia
International Symposium
Prospects for Immune Check Point Inhibitors in Breast Cancer
Panel Discussion
- Terminal Care of Advanced/Recurrent Breast Cancer (public offering session planned)
- Collaboration in fertility and hormone replacement therapy between Breast Cancer Oncologists and Reproductive Medicine Providers
- Oncological Emergencies in Metastatic Breast Cancer (public offering session planned)
- Current Status of the Diagnosis and Treatment for Primary Breast Cancer in Asia
- Approach of multi-disciplinary care for precision medicine-What is the role of nurses?-
- Management of adverse effect in anti-cancer agents for out-patients
- Learn about of acitivity of multi-disciplinary treatments-
Workshop
- Implication of HBOC Counseling to the treatments for breast cancer
- Current Status of treatment for Axilla lymph-nodes (partial designation/public offering session planned)
- Determinants of Cancer Grade – Roles of the Tumor Microenvironment and Intravascular Tumor Emboli
- Development of new anti-breast cancer agents in Japan
Video Symposium
- Mammoplasty Video Symposium – How Breast Removal and Reconstruction Are Performed at Our Department (partial designation/public offering session planned)
- How I Perform Breast Cancer Surgery (public offering session planned)
Patient Program
- Significance of and Issues Concerning a Breast Cancer Diagnosis
- Current Status of and Issues Concerning Job Assistance for Patients with Breast Cancer
Workshop for Resident Doctors
Come and see my presentation